What is the prevalence of Pulmonary atresia?

Pulmonary atresia is a rare congenital heart defect with an estimated incidence of approximately 7 to 9 per 100,000 live births. It is considered a rare condition, and while it is diagnosed primarily in the neonatal period, advancements in surgical interventions have led to an increasing population of adults living with the condition.

How common is Pulmonary atresia and what is its incidence?

Pulmonary atresia is classified as a rare congenital heart defect. According to data from the NIH Genetic and Rare Diseases Information Center (GARD) and Orphanet, the incidence is estimated at roughly 7 to 9 cases per 100,000 live births globally. Because Pulmonary atresia occurs during fetal development, the condition is almost exclusively identified at or shortly after birth. While we have robust data on neonatal incidence, the total prevalence (the number of people currently living with the condition) is harder to quantify precisely because it depends heavily on the long-term survival rates associated with specific surgical outcomes and the complexity of the defect, such as whether it is associated with a ventricular septal defect (VSD) or an intact ventricular septum.

Are there demographic differences in the prevalence of Pulmonary atresia?

Clinical literature indicates that Pulmonary atresia does not show a significant geographic or ethnic bias, affecting populations globally at similar rates. Regarding gender distribution, studies suggest a slight male predominance, though this is not considered clinically defining. The age of onset is strictly pediatric, as the defect originates during embryonic cardiac development. In the community at DiseaseMaps.org, 31 people with Pulmonary atresia have shared their experiences, offering a unique, real-world perspective that complements clinical data by highlighting the lived experiences of patients navigating the transition from pediatric cardiac care to adult congenital cardiology.

What challenges exist in tracking the prevalence of Pulmonary atresia?

Accurate epidemiological tracking of Pulmonary atresia faces several hurdles. These challenges include:

• Diagnostic Complexity: Pulmonary atresia often exists on a spectrum, sometimes being misclassified or grouped with other complex cyanotic heart defects in registry data.


• Reporting Variations: Data collection methods vary by country, with some registries only tracking live births and missing cases that result in pregnancy loss or early neonatal mortality.


• Underdiagnosis of Mild Forms: While severe cases are detected immediately, minor variations or those associated with complex syndromes may occasionally face delays in specific diagnostic sub-categorization.


• Survival Evolution: As surgical techniques improve, the "prevalence" of adults with the condition is changing, making historical data less predictive of the current population size.

Next steps

• Consult a pediatric or adult congenital cardiologist to discuss the specific anatomical subtype of Pulmonary atresia.


• Connect with the 31 members currently sharing their journey on DiseaseMaps.org to understand the long-term management of this condition.


• Request genetic counseling if you are planning a pregnancy, as congenital heart defects can have a complex, though often non-mendelian, genetic component.


• Review resources from the Adult Congenital Heart Association (ACHA) for guidance on specialized lifelong cardiac care.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or qualified health provider with any questions regarding a medical condition.

References

• Orphanet (ORPHA:99960): Rare disease database entry for Pulmonary atresia.


• NIH Genetic and Rare Diseases Information Center (GARD): Pulmonary atresia overview.


• OMIM (Online Mendelian Inheritance in Man): Clinical synopsis for congenital heart defects.


• Adult Congenital Heart Association (ACHA): Patient education and long-term care resources.